Everence Capital Management’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,080
Closed -$211 811
2024
Q2
$211 Hold
2,080
0.01% 670
2024
Q1
$235 Buy
+2,080
New +$208K 0.02% 661
2023
Q3
Sell
-2,080
Closed -$212K 804
2023
Q2
$212K Hold
2,080
0.02% 632
2023
Q1
$204 Buy
+2,080
New +$198K 0.02% 677
2022
Q3
Sell
-2,080
Closed -$227K 748
2022
Q2
$227K Hold
2,080
0.02% 600
2022
Q1
$207K Buy
+2,080
New +$198K 0.02% 685
2021
Q4
Sell
-2,080
Closed -$230K 794
2021
Q3
$230K Hold
2,080
0.02% 646
2021
Q2
$241K Hold
2,080
0.02% 636
2021
Q1
$217K Sell
2,080
-990
-32% -$123K 0.02% 664
2020
Q4
$369K Hold
3,070
0.04% 438
2020
Q3
$267K Sell
3,070
-1,020
-25% -$87.8K 0.03% 500
2020
Q2
$303K Buy
+4,090
New +$298K 0.04% 454
2020
Q1
Sell
-2,050
Closed -$234K 688
2019
Q4
$234K Hold
2,050
0.03% 561
2019
Q3
$268K Hold
2,050
0.04% 466
2019
Q2
$251K Hold
2,050
0.04% 476
2019
Q1
$215K Buy
+2,050
New +$220K 0.04% 523

Other funds holding USPH

Everence Capital Management's USPH Position: Q3 2024 in Review

Everence Capital Management sold out of US Physical Therapy (USPH) in Q3 2024, closing a stake of 2,080 shares — an estimated $211 sold.

Everence Capital Management first reported a position in USPH in Q1 2019 and held it in 16 quarters. The position peaked at $369K in Q4 2020. 257 funds tracked by Wall St. Rank hold USPH as of Q3 2024.

  • Everence Capital Management reported no remaining US Physical Therapy position as of Q3 2024 after selling out during the quarter.
  • Everence Capital Management sold 2,080 US Physical Therapy shares in Q3 2024, an estimated $211.
  • Everence Capital Management first reported a position in US Physical Therapy in Q1 2019 and held it in 16 quarters.
  • Everence Capital Management's US Physical Therapy position peaked at $369K in Q4 2020.
  • 257 funds tracked by Wall St. Rank held US Physical Therapy as of Q3 2024.

Based on Everence Capital Management's 13F filing for Q3 2024, filed 21 Oct 2024.